<DOC>
	<DOC>NCT02136745</DOC>
	<brief_summary>In this pilot study, the investigators examined whether a relaxation response mind-body intervention could be effectively delivered to mixed groups of IBS and IBD patients and determined the effects of the intervention on quality of life, inflammatory markers, and gene expression using transcriptional profiling.</brief_summary>
	<brief_title>Effects of Relaxation Response Mind-body Intervention in Patients With IBS and IBD</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>Patients with documented IBS (confirmed by the Rome III diagnostic criteria for 6 months) or IBD (upper limit for HarveyBradshaw index [HBI] = 20, upper limit of simple clinical colitis activity index [SCCAI] = 18) by their primary care provider or gastroenterologist 1875 years old Fluent in English Patients with IBS were excluded if they had abdominal surgery in the past 5 years (with the exception of appendectomy, cholecystectomy) or documentation of GI motility disorder. Patients with IBD were excluded if they used NSAIDS chronically, were on a prednisone dose â‰¥20 mg/day, or if surgery was anticipated in the 10weeks following enrollment. Current evidence of duodenal ulcer, gastric ulcer, diverticulitis, esophagitis or infectious gastroenteritis, or any acute gastrointestinal process, as well as if concurrent total parental nutrition or tube feeding were being used. Recent (within the last 4weeks) changes in IBS/IBD medications, planned changes in diet, or current use of steroids Currently pregnant or attempting to become pregnant Currently (&gt;3weeks) practicing Tai Chi, meditation, yoga, individual mind/body based psychotherapy or counseling, Initiated psychotherapy within the last 8weeks Using psychotropic medications (except at stable doses for at least 12weeks), Has an untreated psychiatric disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Irritable Bowel Syndrome</keyword>
	<keyword>Inflammatory Bowel Disease</keyword>
	<keyword>mind body</keyword>
	<keyword>intervention</keyword>
	<keyword>group</keyword>
	<keyword>Relaxation Response</keyword>
	<keyword>genomic effects</keyword>
</DOC>